financetom
Business
financetom
/
Business
/
Sterling Infrastructure Q3 Adjusted Earnings, Revenue Rise; Shares Gain After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sterling Infrastructure Q3 Adjusted Earnings, Revenue Rise; Shares Gain After Hours
Nov 3, 2025 2:15 PM

04:53 PM EST, 11/03/2025 (MT Newswires) -- Sterling Infrastructure ( STRL ) posted adjusted Q3 earnings late Monday of $3.48 per diluted share, up from $2.20 a year earlier.

Analysts surveyed by FactSet expected $2.81.

Revenue in the three months ended Sept. 30 rose to $689 million from $593.7 million a year earlier.

Analysts polled by FactSet expected $621.3 million.

The company raised its 2025 guidance to adjusted EPS of $10.35 to $10.52 on revenue of $2.375 billion to $2.39 billion. The previous outlook was adjusted EPS of $9.21 to $9.47 on revenue of $2.1 billion to $2.15 billion.

Analysts expect EPS of $9.45 on revenue of $2.25 billion.

Shares of Sterling Infrastructure ( STRL ) rose 5% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Permian-focused LandBridge to raise $246.5 mln in US IPO
Permian-focused LandBridge to raise $246.5 mln in US IPO
Jun 27, 2024
June 27 (Reuters) - LandBridge ( LB ), a landowner in the oil-rich Permian Basin in the United States, set the pricing of its initial public offering (IPO) at $17 per share to raise around $246.5 million, it said on Thursday. (Reporting by Nilutpal Timsina in Bengaluru; Editing by Janane Venkatraman ) ...
Eisai and Biogen launch Alzheimer's drug Leqembi in China
Eisai and Biogen launch Alzheimer's drug Leqembi in China
Jun 27, 2024
June 28 (Reuters) - Eisai ( ESALF ) and Biogen have launched their Alzheimer's treatment Leqembi in China, the third country after the United States and Japan, the companies said on Friday. Leqembi, which works by removing a toxic protein called beta amyloid from the brain, is the first Alzheimer's treatment proven to alter the course of the fatal, brain-wasting...
BRIEF-Haynes International says CFIUS Approval Obtained For Planned Merger Of North American Stainless And Haynes International
BRIEF-Haynes International says CFIUS Approval Obtained For Planned Merger Of North American Stainless And Haynes International
Jun 27, 2024
June 27 (Reuters) - Haynes International Inc ( HAYN ): * CFIUS APPROVAL OBTAINED FOR THE PLANNED MERGER OF NORTH AMERICAN STAINLESS, INC. AND HAYNES INTERNATIONAL, INC. ( HAYN ) Source text for Eikon: Further company coverage: ...
Oasis announces campaign on Japan's largest drug store chain
Oasis announces campaign on Japan's largest drug store chain
Jun 27, 2024
TOKYO, June 28 (Reuters) - Activist investor Oasis Management has called for governance overhaul at scandal-hit Ain Holdings ( AINPF ), Japan's largest drug store chain, in its latest activist campaign targeting a Japanese company. Oasis said there was no independent oversight of management at Ain and proposed four new outside director candidates as well as a new compensation plan...
Copyright 2023-2026 - www.financetom.com All Rights Reserved